Volume 69, Issue 1, Pages 4-6 (January 2016)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Volume 60, Issue 4, Pages (October 2011)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

Volume 60, Issue 2, Pages (August 2011)

Renal Cell Carcinoma: Prognostic Factors and Patient Selection

Volume 71, Issue 2, Pages (February 2017)

Volume 61, Issue 5, Pages (May 2012)

Volume 51, Issue 1, Pages (January 2007)

Volume 73, Issue 3, Pages (March 2018)

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 5, Pages (May 2012)

Volume 53, Issue 5, Pages (May 2008)

Volume 54, Issue 4, Pages (October 2008)

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Let the Games Begin (with EAU Approval)

Volume 68, Issue 1, Pages (July 2015)

Prostate Cancer Epidemic in Sight?

Giuseppe Di Lorenzo, Riccardo Autorino, Cora N. Sternberg

Volume 50, Issue 5, Pages (November 2006)

Volume 59, Issue 2, Pages (February 2011)

Volume 63, Issue 1, Pages (January 2013)

Toxicities of Targeted Therapy and Their Management in Kidney Cancer

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Volume 66, Issue 2, Pages (August 2014)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 51, Issue 3, Pages (March 2007)

Volume 71, Issue 1, Pages 1-3 (January 2017)

Volume 52, Issue 5, Pages (November 2007)

Volume 68, Issue 1, Pages 5-7 (July 2015)

Volume 71, Issue 3, Pages (March 2017)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 65, Issue 4, Pages (April 2014)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 68, Issue 1, Pages (July 2015)

Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma Viktor Grünwald, Xun Lin, Daniel Kalanovic,

Volume 60, Issue 5, Pages (November 2011)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Laurent Boccon-Gibod European Urology Supplements

Prostate Cancer Epidemic in Sight?

Volume 61, Issue 6, Pages (June 2012)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 5, Pages (November 2014)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Volume 47, Issue 1, Pages (January 2005)

Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection

Volume 53, Issue 1, Pages (January 2008)

Is Simple Enucleation a Minimal Partial Nephrectomy Responding to the EAU Guidelines’ Recommendations? Vincenzo Ficarra, Antonio Galfano, Stefano Cavalleri

Volume 50, Issue 5, Pages (November 2006)

Mammalian Target of Rapamycin Inhibitors in Clinical Practice: Case Reports of Everolimus in Renal Cell Carcinoma Sergio Bracarda, Alain Ravaud, Marino.

Volume 73, Issue 2, Pages (February 2018)

Testicular Cancer Variations in Time and Space in Europe

Volume 53, Issue 1, Pages (January 2008)

Volume 54, Issue 4, Pages (October 2008)

Bernard Escudier European Urology Supplements

Sergio Bracarda European Urology Supplements

European Urology is “Your” Journal

Epidemiology of Renal Cell Carcinoma

Volume 51, Issue 6, Pages (June 2007)

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Annika Berntsen, Poul F. Geertsen, Inge Marie Svane European Urology

Joaquim Bellmunt European Urology Supplements

Volume 76, Issue 1, Pages (July 2019)

Jan Roigas European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

Update on the Medical Treatment of Metastatic Renal Cell Carcinoma

Volume 51, Issue 5, Pages (May 2007)

Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma Guillermo de Velasco, Axel Bex, Laurence Albiges, Thomas Powles, Brian.

Presentation transcript:

Volume 69, Issue 1, Pages 4-6 (January 2016) Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy Thomas Powles, Michael Staehler, Börje Ljungberg, Karim Bensalah, Steven E. Canfield, Saeed Dabestani, Rachel Giles, Fabian Hofmann, Milan Hora, Markus A. Kuczyk, Thomas Lam, Lorenzo Marconi, Axel S. Merseburger, Alessandro Volpe, Axel Bex European Urology Volume 69, Issue 1, Pages 4-6 (January 2016) DOI: 10.1016/j.eururo.2015.10.017 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 Recommendations for patients with metastatic renal cell carcinoma who have failed one line or more of vascular endothelial growth factor receptor-targeted therapy. OS=overall survival. European Urology 2016 69, 4-6DOI: (10.1016/j.eururo.2015.10.017) Copyright © 2015 European Association of Urology Terms and Conditions